Safety and Efficacy of Osimertinib in Patients with NSCLC and Uncommon Tumoral EGFR Mutations: A Systematic Review and Meta-Analysis.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2024)